McKnight began her career in Washington, D.C., and focuses her national practice on advising companies on Food and Drug Administration regulatory and compliance matters. She guides companies on regulatory aspects related to bringing new products to market – including clinical trials and the collection, sharing and use of patient and product information – and maintaining compliant operations in the areas of manufacturing, distribution, and promotion and advertising. She is especially attuned to the compliance needs of clients navigating the late stages of clinical development and making the transition to their first commercial launch.
“Becca has extensive experience and a keen understanding of issues related to traditional health care and pharmaceutical sectors and the convergence with technology,” said Scot Hasselman, co-chair of Reed Smith’s Life Sciences Health Industry Group. “She bolsters our FDA regulatory capabilities at a time when companies are facing evolving challenges related to compliance and enforcement. We’re thrilled that she has decided to join the team.”
McKnight also assists clients with developing FDA and health care compliance policies and procedures, and conducting risk assessments and compliance investigations. Reed Smith’s stellar reputation in the health care and life sciences sectors and commitment to diversity, mental health and positive firm culture were among the reasons she decided to make the move.
“The history of the Reed Smith brand in health care and life sciences, as well as clear intentionality in the growth of that practice, are among the reasons I decided to join the firm,” McKnight said. “The firm also has garnered a reputation for action in key areas in the legal profession, including diversity and equity, and mental health programs, which are very important to me. I’m excited to be a part of the expansion here in the Austin office.”
McKnight began her law practice at King & Spalding prior to joining DLA Piper in 2005. She earned her B.A. from Wake Forest University and her J.D., with honors, from the University of Texas School of Law. She has served on several Food & Drug Law Institute (FDLI) committees and was recently named to the American Lawyer’s inaugural list of South Trailblazers, in recognition of her FDA practice in Austin and her commitment to supporting diversity in the legal community. In addition to her active law practice, she serves on the Advisory Council of Divine Canines, a nonprofit organization dedicated to providing free therapy dog services to people across Central Texas facing challenges related to mental illness, physical and developmental limitations, dementia, and PTSD following military service.
“Becca’s practice and experience complement and add substantial depth to our FDA regulatory practice,” said Jeff Layne, managing partner of the Austin office. “She has deep knowledge and understanding of the Austin business market, as well as the rapidly evolving challenges facing our pharma, biotech and medical device clients. With Becca’s addition to the team, Reed Smith has the premier life sciences practice in Austin.”
About Reed Smith
Reed Smith is a dynamic international law firm dedicated to helping clients move their businesses forward. With an inclusive culture and innovative mindset, we deliver smarter, more creative legal services that drive better outcomes for our clients. Our deep industry knowledge, long-standing relationships and collaborative structure make us the go-to partner for complex disputes, transactions, and regulatory matters.
For more information, please visit www.reedsmith.com.
